JP2021529173A5 - - Google Patents
Info
- Publication number
- JP2021529173A5 JP2021529173A5 JP2020570909A JP2020570909A JP2021529173A5 JP 2021529173 A5 JP2021529173 A5 JP 2021529173A5 JP 2020570909 A JP2020570909 A JP 2020570909A JP 2020570909 A JP2020570909 A JP 2020570909A JP 2021529173 A5 JP2021529173 A5 JP 2021529173A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cancer
- nucleotide sequence
- rig
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687606P | 2018-06-20 | 2018-06-20 | |
| US62/687,606 | 2018-06-20 | ||
| US201862743369P | 2018-10-09 | 2018-10-09 | |
| US62/743,369 | 2018-10-09 | ||
| US201962815870P | 2019-03-08 | 2019-03-08 | |
| US62/815,870 | 2019-03-08 | ||
| PCT/US2019/038323 WO2019246450A1 (en) | 2018-06-20 | 2019-06-20 | Rig-i agonists and treatments using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021529173A JP2021529173A (ja) | 2021-10-28 |
| JP2021529173A5 true JP2021529173A5 (cg-RX-API-DMAC10.html) | 2022-06-10 |
Family
ID=68982664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570909A Pending JP2021529173A (ja) | 2018-06-20 | 2019-06-20 | Rig−iアゴニストおよびそれを使用した処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US12472198B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3810151B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2021529173A (cg-RX-API-DMAC10.html) |
| CN (1) | CN112672748A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3110102A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2019246450A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016146143A1 (en) | 2015-03-16 | 2016-09-22 | Amal Therapeutics Sa | Cell penetrating peptides and complexes comprising the same |
| EP3429618B1 (en) | 2016-03-16 | 2024-02-21 | Amal Therapeutics SA | Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicine |
| KR20190057345A (ko) | 2016-09-21 | 2019-05-28 | 아말 테라퓨틱스 에스에이 | 암 치료를 위한, 세포 투과 펩타이드, 멀티 에피토프 및 tlr 펩타이드 작용제를 포함하는 융합체 |
| CN119286871A (zh) | 2018-04-19 | 2025-01-10 | 查美特制药公司 | 合成rig-i样受体激动剂 |
| EP3863675A4 (en) * | 2018-10-09 | 2023-09-06 | Yale University | RIG-I AGONISTS AND METHODS OF USE THEREOF |
| CA3155202A1 (en) | 2019-10-23 | 2021-04-29 | Arthur M. Krieg | Synthetic rig-i-like receptor agonists |
| CA3156933A1 (en) * | 2019-11-04 | 2021-05-14 | Anna Marie Pyle | Rig-i innate immune receptor antagonists and methods of using same |
| WO2022079175A1 (en) * | 2020-10-14 | 2022-04-21 | Boehringer Ingelheim International Gmbh | Combination of a sting agonist and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist |
| US11786545B2 (en) * | 2020-12-09 | 2023-10-17 | Yale University | Compositions and methods for treating SARS-CoV-2 infection |
| KR20240043747A (ko) | 2021-07-02 | 2024-04-03 | 예일 유니버시티 | 암을 치료하기 위한 조성물 및 방법 |
| JP2024532621A (ja) | 2021-08-31 | 2024-09-05 | イエール ユニバーシティ | がんを治療するための組成物および方法 |
| AU2023228912A1 (en) | 2022-03-03 | 2024-09-19 | Yale University | Humanized 3e10 antibodies, variants, and antigen binding fragments thereof |
| CN114814231B (zh) * | 2022-03-08 | 2024-08-27 | 上海交通大学医学院附属瑞金医院 | 维甲酸诱导基因i在癌症治疗中的应用 |
| CN117379551A (zh) * | 2022-07-04 | 2024-01-12 | 中国科学院上海营养与健康研究所 | 一种肿瘤联合治疗疗法 |
| WO2025040743A1 (en) | 2023-08-22 | 2025-02-27 | Univerza V Ljubljani | Conjugated tlr7 and rig-i agonists |
| WO2026039779A1 (en) | 2024-08-15 | 2026-02-19 | Yale University | Humanized 3e10 antibodies and antigen binding fragments optimized for rad51 binding |
| WO2026112449A1 (en) | 2024-11-21 | 2026-05-28 | Rigimmune Inc. | Formulations |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| US5350674A (en) | 1992-09-04 | 1994-09-27 | Becton, Dickinson And Company | Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof |
| US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
| FR2722506B1 (fr) | 1994-07-13 | 1996-08-14 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucleiques, preparation et utilisations |
| ES2192672T3 (es) | 1996-11-18 | 2003-10-16 | Takeshi Imanishi | Nuevos analogos de nucleotidos. |
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| US6143877A (en) | 1997-04-30 | 2000-11-07 | Epoch Pharmaceuticals, Inc. | Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids |
| EP1015469B2 (en) | 1997-09-12 | 2015-11-18 | Exiqon A/S | Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| US6127121A (en) | 1998-04-03 | 2000-10-03 | Epoch Pharmaceuticals, Inc. | Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination |
| IL145496A0 (en) | 1999-03-24 | 2002-06-30 | Exiqon As | Improved synthesis of [2.2.1] bicyclo nucleosides |
| ATE356824T1 (de) | 1999-05-04 | 2007-04-15 | Santaris Pharma As | L-ribo-lna analoge |
| US6287778B1 (en) | 1999-10-19 | 2001-09-11 | Affymetrix, Inc. | Allele detection using primer extension with sequence-coded identity tags |
| US6660845B1 (en) | 1999-11-23 | 2003-12-09 | Epoch Biosciences, Inc. | Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| US20090247613A1 (en) | 2002-02-20 | 2009-10-01 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED INHIBITION OF B-CELL CLL/LYMPHOMA-2 (BCL2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| US8017737B2 (en) | 2002-11-19 | 2011-09-13 | Hasan Kulaksiz | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| US20070270360A1 (en) | 2003-04-15 | 2007-11-22 | Sirna Therapeutics, Inc. | Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid |
| CA2538169A1 (en) | 2003-09-09 | 2005-03-17 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state analog inhibitors of ricin a-chain |
| US20080293053A1 (en) | 2006-12-28 | 2008-11-27 | The Regents Of The University Of Michigan | shRNA Materials and Methods of Using Same for Inhibition of DKK-1 |
| WO2009023333A2 (en) | 2007-05-17 | 2009-02-19 | Baylor College Of Medicine | Inhibition of the sh2-domain containing protein tyr-phosphatase, shp-1, to enhance vaccines |
| AU2009215795A1 (en) | 2008-02-21 | 2009-08-27 | University Of Kentucky Research Foundation | Ultra-small RNAs as toll-like receptor-3 antagonists |
| US8575123B2 (en) | 2008-04-11 | 2013-11-05 | Tekmira Pharmaceuticals Corporation | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| US9738680B2 (en) | 2008-05-21 | 2017-08-22 | Rheinische Friedrich-Wilhelms-Universität Bonn | 5′ triphosphate oligonucleotide with blunt end and uses thereof |
| CA2731779A1 (en) | 2008-07-24 | 2010-01-28 | Rxi Pharmaceuticals Corporation | Rnai constructs and uses therof |
| WO2010045384A2 (en) | 2008-10-15 | 2010-04-22 | Somagenics Inc. | Short hairpin rnas for inhibition of gene expression |
| US8563710B2 (en) | 2009-04-03 | 2013-10-22 | Biomics Biotechnologies Co., Ltd. | Modified oligonucleotide and its preparation and application |
| EP2508530A1 (en) | 2011-03-28 | 2012-10-10 | Rheinische Friedrich-Wilhelms-Universität Bonn | Purification of triphosphorylated oligonucleotides using capture tags |
| JP2015502365A (ja) | 2011-12-12 | 2015-01-22 | オンコイミューニン,インコーポレイティド | オリゴヌクレオチドのイン−ビボ送達 |
| US10947543B2 (en) * | 2013-03-13 | 2021-03-16 | Yale University | Interferon production using short RNA duplexes |
| CU24377B1 (es) * | 2013-05-18 | 2018-12-05 | Aduro Biotech Inc | Dinucléotidos de purina cíclicos y composiciones de los mismos útiles para inducir la producción de interferón de tipo i dependientes de sting |
| CN106794246B (zh) | 2014-08-08 | 2021-10-15 | OncoQuest制药有限公司 | 肿瘤抗原特异性抗体和tlr3刺激以增强检查点干扰癌症疗法的性能 |
| CA3014759C (en) * | 2016-02-15 | 2020-09-22 | FKD Therapies Limited | Improved interferon therapy |
| EP3436031A4 (en) | 2016-04-01 | 2019-09-18 | Vycellix, Inc. | Novel RNA construct and method of use therefor for increasing the therapeutic effects of cytotoxic cells and stem cells |
| CN109715205A (zh) | 2016-08-19 | 2019-05-03 | 库瑞瓦格股份公司 | 用于癌症治疗的rna |
| WO2018172546A1 (en) * | 2017-03-24 | 2018-09-27 | Rigontec Gmbh | Method for designing rig-i ligands |
| US10710272B2 (en) | 2017-12-14 | 2020-07-14 | United Technologies Corporation | Hybrid material airflow impression molds |
| US10736957B2 (en) | 2017-12-19 | 2020-08-11 | President And Fellows Of Harvard College | Enhanced immunogenicity of mRNA with co-encoded adjuvant sequences |
| JP7386161B2 (ja) | 2017-12-19 | 2023-11-24 | ブレイズ バイオサイエンス, インコーポレイテッド | 腫瘍ホーミング及び細胞透過性ペプチド免疫抗がん剤複合体、ならびにそれらの使用方法 |
| WO2019136432A1 (en) * | 2018-01-08 | 2019-07-11 | Novartis Ag | Immune-enhancing rnas for combination with chimeric antigen receptor therapy |
| US11499157B2 (en) * | 2018-01-17 | 2022-11-15 | Nanyang Technological University | Immunomodulatory small hairpin RNA molecules |
| CN119286871A (zh) | 2018-04-19 | 2025-01-10 | 查美特制药公司 | 合成rig-i样受体激动剂 |
-
2019
- 2019-06-20 EP EP19822447.9A patent/EP3810151B1/en active Active
- 2019-06-20 JP JP2020570909A patent/JP2021529173A/ja active Pending
- 2019-06-20 US US17/251,921 patent/US12472198B2/en active Active
- 2019-06-20 CA CA3110102A patent/CA3110102A1/en active Pending
- 2019-06-20 WO PCT/US2019/038323 patent/WO2019246450A1/en not_active Ceased
- 2019-06-20 CN CN201980055031.8A patent/CN112672748A/zh not_active Withdrawn
- 2019-09-03 US US16/558,564 patent/US20200061097A1/en not_active Abandoned
-
2022
- 2022-07-13 US US17/864,199 patent/US20230201242A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI784934B (zh) | 抑制lpa之基因表現之組合物及方法 | |
| AU2024202093A1 (en) | Peptides and nanoparticles for intracellular delivery of mrna | |
| KR102737464B1 (ko) | 안지오포이에틴-유사 3 (ANGPTL3)의 발현을 억제하기 위한 RNAi 작용제 및 조성물, 및 사용 방법 | |
| JP7830340B2 (ja) | PNPLA3の発現を阻害するためのRNAi薬、その医薬組成物、及び使用方法 | |
| JP2021533804A5 (cg-RX-API-DMAC10.html) | ||
| RU2015119409A (ru) | Конъюгаты олигонуклеотидов | |
| JP2007529224A5 (cg-RX-API-DMAC10.html) | ||
| TW201639962A (zh) | Rna干擾劑 | |
| JP2023503635A (ja) | Rna分子を合成する方法 | |
| EP4665854A1 (en) | Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof | |
| CN114369130A (zh) | 修饰的硫代寡核苷酸及其应用 | |
| CN116077673B (zh) | 一种f碱基白蛋白药物运载体系及其制备方法和用途 | |
| JP2022507425A (ja) | Foxp3発現のモジュレータ | |
| JP2022512651A5 (cg-RX-API-DMAC10.html) | ||
| US20260092281A1 (en) | Methods for treatment of anemia | |
| EP4396347B1 (en) | Chimeric complex and therapeutic uses thereof | |
| RU2022105124A (ru) | Нуклеиновые кислоты для ингибирования экспрессии c3 в клетке | |
| WO2026069321A1 (en) | Nucleic acids for inhibiting expression of transferrin receptor 2 | |
| HK40113403A (en) | Cyclic structured oligonucleotides as therapeutic agents | |
| HK40129500A (en) | Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof | |
| JP2026511268A (ja) | 化学修飾ヌクレオチド | |
| HK1259063B (en) | Compositions and methods for inhibiting gene expression of lpa |